Research report: Repurposing the phospholipase A2 inhibitor, darapladib, to combat multidrug-resistant fungal pathogens, including Candida auris
A screen of about 2,600 approved drugs identified the phospholipase A2 inhibitor darapladib as a potent, resistance-resistant antifungal candidate against ...
